Categories: CancerNews

The Assistance Fund Opens New Program for Small Cell Lung Cancer

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Small Cell Lung Cancer

ORLANDO, FL / ACCESSWIRE / July 22, 2023 / The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program for people living with small cell lung cancer. The program is designed to help eligible individuals pay for their out-of-pocket medical expenses related to small cell lung cancer, such as copays, coinsurance, and deductibles.

Small cell lung cancer is most closely associated with heavy smoking and tobacco use.[1] People living with small cell lung cancer experience difficulty breathing, wheezing, hoarseness, and fatigue. Categorized as limited-stage or extensive-stage, this cancer often requires surgery, radiation, or chemotherapy treatment.

“The only thing cancer patients should be focused on is getting better, not the cost of care,” said Danielle Vizcaino, President and CEO at The Assistance Fund. “Because of the generosity of our donors, TAF’s Small Cell Lung Cancer Copay Assistance Program-our seventeenth oncology disease program-will ensure more people living with small cell lung cancer get the potentially lifesaving treatment they need.”

To learn more or determine eligibility for financial support, visit tafcares.org or call (855) 440-1985 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages nearly 90 disease programs, each of which covers all the FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped nearly 180,000 children and adults access the treatment they need to stay healthy or manage a life-threatening, chronic, or rare disease. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

[1] Mayo Clinic, “Lung cancer,” https://www.mayoclinic.org/diseases-conditions/lung-cancer/symptoms-causes/syc-20374620, accessed May 2023.

Contact Information

Margaret Figley
Senior Director of Communications
margaret.figley@tafcares.org

SOURCE: The Assistance Fund

View source version on accesswire.com:
https://www.accesswire.com/769179/The-Assistance-Fund-Opens-New-Program-for-Small-Cell-Lung-Cancer

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

11 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

14 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

14 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

14 hours ago